OA

Olympia Apokotou

Doctoral Student at Hellenic Pasteur Institute

Olympia Apokotou is a Doctoral Student at the Hellenic Pasteur Institute, focusing on neuron-glia interactions in Parkinson's disease. Previous experience includes roles as a Staff Scientist, where work involved maintaining patient-derived hiPSCs, generating induced neurons, and creating neuron/glia co-cultures and 3D midbrain-like organoids. As a Master's Student, research concentrated on synaptic connectivity and proteostasis in the A53T transgenic mouse model of Parkinson's disease. Olympia also served as a Research Intern at the Biomedical Research Foundation of the Academy of Athens, studying transgenic models of Alzheimer's disease, and as an Undergraduate Research Assistant at the National & Kapodistrian University of Athens, investigating NMDAR signaling. Educational qualifications include a Doctor of Philosophy in Cellular Neurobiology (currently pursuing), a Master of Science in Clinical Biochemistry and Molecular Diagnostics, and a Bachelor of Science in Biology from the National & Kapodistrian University of Athens.

Location

Πειραιάς, Greece

Links


Org chart

This person is not in the org chart


Teams


Offices


Hellenic Pasteur Institute

HPI, is a private, non-profit organization, operating under the auspices of the General Secretariat of Research and Technology and the Ministry of Health and Welfare. Today, the dynamic presence of the HPI in the field of Biomedical Science and Public Health is worthy of its long tradition as a Research Institute in the Service of Public Health. The study of infectious diseases constitutes the main focus of the Institute’s research activities, with pioneering contributions in the field. At the same time, new developments in the fields of immunology and neurobiology allowed the Institute to contribute significantly towards the understanding of pathogenesis and the development of therapeutic strategies for auto-immune and neuro-degenerative diseases of the nervous system. Special emphasis is given to: The development of new diagnostic systems for the detection of infectious agents or pathogens causing diseases of major importance for animal and human health, including Echinococcus, Helicobacter pylori, Hepatitis C virus, Herpes Simplex virus, and Leishmania parasite, to name a few. The development of new generation vaccines, in particular against Hepatitis C and leishmaniasis. The understanding of the mechanisms of pathogenesis of auto-immune diseases (i.e. myasthenia gravis, rheumatoid arthritis, multiple sclerosis), disorders of the brain and neuro-degenerative diseases as well as infectious diseases, with the aim to contribute to the improvement of their diagnosis and treatment. There is ongoing work on pioneering methods of treatment such as gene therapy and transplant of genetically modified stem cells with improved therapeutic capacity. Services rendered in the area of public health, such as microbiological control of foods and drinks for various industrial units of the country and the control of efficacy of antiseptic and other disinfectant substances.


Headquarters

Greece

Employees

51-200

Links